Chirality-Driven Metal–Phenolic Artificial Enzymes Enable Renal Targeting and Antioxidative Therapy Enhancement for Acute Kidney Injury
Journal of the American Chemical Society · 17.12.2025 · 147 (50) · 45977-45998
DOI: 10.1021/jacs.5c12337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 06.12.2025. Verfasst von Zhiwei Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu 610065, China. Hauptthemen laut MEDLINE: Antioxidants, Acute Kidney Injury, Copper, Phenylalanine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: State Key Laboratory of Polymer Materials Engineering, Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Despite advancements in artificial enzymes (AEs) for acute kidney injury (AKI) therapy through renal redox homeostasis modulation, the trade-off between organ-specific targeting and high multienzyme-mimicking catalytic efficiency is still a big challenge. Herein, we address this challenge through chirality-engineered Cu 2+ -phenolic AEs ( l -phen@Cu-TA) via incorporation of l -phenylalanine ( l -phen) to synergize stereoselective recognition and catalytic activity. Chiral l -phen induces electron density redistribution from phenolic ligands to Cu 2+ in the cocatalytic center, significantly enhancing H 2 O 2 adsorption while reducing catalytic energy barriers, thereby amplifying catalase (CAT)-mimicking activity and superoxide dismutase (SOD)-mimetic performance, with concurrent scavenging of secondary radicals ( • OH, ONOO –, etc.). Critically, the stereoselective recognition of l -phen@Cu-TA AEs, based on the l -type amino acid transporter 1 (LAT1), enhances the renal tubular cell uptake by 5-fold over pristine Cu-TA AEs, respectively, thereby driving renal pathological-site enrichment and internalization to boost therapeutic bioavailability. In vivo investigation reveals that the l -phen@Cu-TA treatment can restore the physiological homeostasis of AKI via ROS-scavenging by SOD–CAT enzymatic cascades and remodel the renal microenvironmental stability, thereby achieving satisfactory AKI treatment. This work pioneers chirality-modulated AEs for organ-specific antioxidant therapy, establishing a transformative paradigm for precision intervention in oxidative stress-related pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu 610065, China.
- Department of Nephrology, Kidney Research Institute, Innovation Center for Wound Repair, West China Hospital, Chengdu 610041, China.
- State Key Laboratory of Solid Lubrication Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
ORCID-Profile: Zhiwei Wei, Zhibin Lu, Yi Xie
Förderung
- State Key Laboratory of Polymer Materials Engineering
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Wei, Z., Wang, L., Yang, L., Chen, S., Chen, Y., Lu, Z., Zhang, K., Su, B., Xie, Y., & Zhao, C. (2025). Chirality-Driven Metal–Phenolic Artificial Enzymes Enable Renal Targeting and Antioxidative Therapy Enhancement for Acute Kidney Injury. Journal of the American Chemical Society, 147(50), 45977-45998. https://doi.org/10.1021/jacs.5c12337
Vancouver
Wei Z, Wang L, Yang L, Chen S, Chen Y, Lu Z, et al. Chirality-Driven Metal–Phenolic Artificial Enzymes Enable Renal Targeting and Antioxidative Therapy Enhancement for Acute Kidney Injury. Journal of the American Chemical Society. 2025;147(50):45977-45998. doi:10.1021/jacs.5c12337
BibTeX
@article{Wei2025,
author = {Wei, Zhiwei and Wang, Liya and Yang, Li and Chen, Shengqiu and Chen, Yiming and Lu, Zhibin and Zhang, Ke and Su, Baihai and Xie, Yi and Zhao, Changsheng},
title = {Chirality-Driven Metal–Phenolic Artificial Enzymes Enable Renal Targeting and Antioxidative Therapy Enhancement for Acute Kidney Injury},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {50},
pages = {45977--45998},
doi = {10.1021/jacs.5c12337}
}
EUVIMED